A Study to Evaluate the Safety, Pharmacokinetics, and Activity of Enzelkitug as a Single Agent and in Combination With Checkpoint Inhibitor in Participants With Locally Advanced or Metastatic Solid Tumors
Genentech, Inc.
Genentech, Inc.
National Cancer Institute (NCI)
AbbVie
Jazz Pharmaceuticals
Exscientia AI Limited
Seagen Inc.
Alliance for Clinical Trials in Oncology
AstraZeneca
Aulos Bioscience, Inc.
EMD Serono
AstraZeneca
University of California, Irvine
Neonc Technologies, Inc.
ViroMissile, Inc.
Seagen Inc.
Arvinas Inc.
Tizona Therapeutics, Inc
Brigham and Women's Hospital
Baylor College of Medicine
MacroGenics
Daiichi Sankyo
One-carbon Therapeutics AB
University of Nebraska
Zhejiang University
Adela, Inc
Perspective Therapeutics
Innate Pharma
Dren Bio
Var2 Pharmaceuticals
Tanabe Pharma America, Inc.
Massive Bio, Inc.
LigaChem Biosciences, Inc.
Washington University School of Medicine
Nurix Therapeutics, Inc.
Jonsson Comprehensive Cancer Center
Medicenna Therapeutics, Inc.
Marengo Therapeutics, Inc.
Apollomics Inc.
University of California, Irvine
ModeX Therapeutics, An OPKO Health Company
Cancer Research UK
Columbia University
Merus B.V.
Pack Health
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Taiho Pharmaceutical Co., Ltd.
European Organisation for Research and Treatment of Cancer - EORTC
Cancer Research UK
Zhujiang Hospital
Second Affiliated Hospital of Guangzhou Medical University